Neusspray Xelf (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Neusspray Xelf, is an imidazoline nasal decongestant presented as a nasal spray for nasal use. It provides temporary relief of nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children over the recommended age.

GNH USA supplies Neusspray Xelf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neusspray Xelf, an imidazoline nasal decongestant, is used to alleviate nasal congestion in several common upper‑respiratory conditions.

- Common cold nasal congestion: reduces swelling of nasal mucosa to improve airflow. - Sinusitis‑related congestion: eases blockage caused by inflamed sinus passages. - Allergic rhinitis: alleviates congestion due to allergen‑induced nasal inflammation.

Xylometazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal burning or stinging sensation. - Dryness of the nasal mucosa. - Sneezing. - Headache. - Altered taste or smell.

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) after prolonged use. - Severe hypertension or cardiac arrhythmia. - Allergic reactions such as rash, itching, swelling, or anaphylaxis.

When using Neusspray Xelf, certain precautions should be observed to ensure safe and effective use.

- Pregnancy: consult a healthcare professional as safety has not been established. - Breastfeeding: use with caution; limited data are available. - Duration of use: limit treatment to 3–5 days to avoid rebound congestion. - Age restrictions: not recommended for children under 6 years unless directed by a physician. - Cardiovascular conditions: use cautiously in patients with hypertension or heart disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines, altering its effects or increasing the risk of adverse events.

Major Interactions (Avoid): - Concurrent use of other nasal decongestants: may cause excessive vasoconstriction and elevated blood pressure. - Monoamine oxidase inhibitors (MAOIs): can potentiate hypertensive responses.

Moderate Interactions (Monitor Closely): - Sympathomimetic agents (e.g., pseudoephedrine): may increase cardiovascular stimulation. - Antihypertensive drugs: nasal decongestant may reduce their efficacy, requiring blood pressure monitoring. - Beta‑blockers: may blunt compensatory heart‑rate changes during vasoconstriction.